about
Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidaseFDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project OrbisFast-track pathways for drug approvals: the Australian experience so far
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sarah J Golding
@en
Sarah J Golding
@nl
type
label
Sarah J Golding
@en
Sarah J Golding
@nl
prefLabel
Sarah J Golding
@en
Sarah J Golding
@nl
P31
P496
0000-0002-6578-4390